193 related articles for article (PubMed ID: 1441531)
1. [Severe exacerbation of chronic hepatitis B following interferon therapy].
Laskus T; Radkowski M; Cianciara J; Loch T; Slusarczyk J
Wiad Lek; 1992 Jun; 45(11-12):458-61. PubMed ID: 1441531
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis delta superinfection during alpha-interferon treatment for hepatitis B.
Craxì A; Di Marco V; Bruno R; Fabiano C
Ital J Gastroenterol; 1992 Jan; 24(1):19-20; discussion 20-1. PubMed ID: 1571575
[TBL] [Abstract][Full Text] [Related]
3. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
[TBL] [Abstract][Full Text] [Related]
5. [Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].
Janssen HL; Berk L; de Man RA; Heijtink RA; Schalm SW
Ned Tijdschr Geneeskd; 1992 Apr; 136(17):835-9. PubMed ID: 1522928
[TBL] [Abstract][Full Text] [Related]
6. [Reactivation of virus replication during immunosuppressive therapy in children with chronic hepatitis B].
Giacchino R; Facco F; Loy A; Timitilli A; Cirillo C; Navone C; Ciravegna B; Pisani N
Boll Ist Sieroter Milan; 1989; 68(1):24-7. PubMed ID: 2491283
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of chronic hepatitis B with interferon].
Vogel W
Wien Med Wochenschr; 1993; 143(16-17):458-60. PubMed ID: 8273372
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study of lamivudine and interferon combinate administration to inhibit hepatitis B virus replication].
Song JW; Zhang G; Lin JG; Tang WX; Lin JS
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):593-6. PubMed ID: 15504288
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic hepatitis B.
Schalm SW
Neth J Med; 1994 Mar; 44(3):103-9. PubMed ID: 8202205
[TBL] [Abstract][Full Text] [Related]
10. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
Marinos G; Naoumov NV; Williams R
Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of chronic hepatitis B, C and D with alpha-interferon].
Niederau C
Fortschr Med; 1993 Feb; 111(6):35-7. PubMed ID: 8462911
[No Abstract] [Full Text] [Related]
12. [Preliminary results of the treatment of patients with chronic active hepatitis (CAH) HBsAg+,HBeAg+ with low oral doses of human interferon-alpha].
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz J; Cummins J; Georgiades J
Przegl Epidemiol; 1991; 45(4):325-30. PubMed ID: 1841411
[TBL] [Abstract][Full Text] [Related]
13. Permanent inhibition of viral replication induced by low dosage of human leukocyte interferon in patients with chronic hepatitis B.
Pastore G; Santantonio T; Monno L; Milella M; Luchena N; Angarano G
Hepatogastroenterology; 1988 Apr; 35(2):57-61. PubMed ID: 3371847
[TBL] [Abstract][Full Text] [Related]
14. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis.
Georgetson MJ; Yarze JC; Lalos AT; Webster GF; Martin P
Am J Gastroenterol; 1993 Oct; 88(10):1756-8. PubMed ID: 8213720
[TBL] [Abstract][Full Text] [Related]
15. Circulating ICAM-1 (sCD54) and LFA-3 (sCD58) in chronic hepatitis B--a longitudinal study in patients treated with interferon-alpha.
Knolle PA; Eckardt AJ; Protzer-Knolle U; Schirmacher P; Dienes HP; Meyer zum Büschenfelde KH; Gerken G
Z Gastroenterol; 1997 Jun; 35(6):459-67. PubMed ID: 9231990
[TBL] [Abstract][Full Text] [Related]
16. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
17. [Chronic hepatitis B: diagnostic value of hepatitis-B-virus DNA analysis in serum and liver tissue].
Meier P; Walter E; Blum HE; Offensperger WB; Offensperger S; Schmid M; Gerok W
Schweiz Med Wochenschr; 1990 Mar; 120(9):310-3. PubMed ID: 2156336
[TBL] [Abstract][Full Text] [Related]
18. Natural history and therapy of chronic hepatitis B virus infection.
Alexander GJ; Williams R
Am J Med; 1988 Aug; 85(2A):143-6. PubMed ID: 3044078
[TBL] [Abstract][Full Text] [Related]
19. [The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results].
Kokoreva LN; Zmyzgova AV; Shalygina NB
Ter Arkh; 1996; 68(2):10-4. PubMed ID: 8771646
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of chronic viral hepatitis].
Marcellin P; Metreau JM; Pol S; Zoulim F
Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
[No Abstract] [Full Text] [Related]
[Next] [New Search]
